ProHealth Hospice LLC and affiliated entities agreed to pay $18.5 million to resolve False Claims Act allegations that the regional hospice provider enrolled Medicare beneficiaries who did not meet the statutory terminal prognosis requirement for hospice eligibility, and retained patients on hospice enrollment beyond periods supported by the clinical documentation — generating Medicare claims for hospice services that the program was not designed and not legally authorized to pay for the enrolled population.DOCUMENTED
Medicare hospice is a defined benefit available to beneficiaries whose physician certifies a prognosis of six months or fewer to live if the terminal illness follows its expected course. Patients who enroll in hospice elect to forego curative treatment in favor of palliative and comfort care, and Medicare covers hospice services — including nursing, aide, social work, and chaplaincy visits, as well as drugs and supplies related to the terminal diagnosis — at a per-diem rate for as long as the patient remains eligible. Hospice providers that enroll ineligible patients or retain patients past the point of clinical eligibility receive per-diem payments from Medicare that are not authorized under the hospice benefit and that constitute false claims under federal law.REVIEWED
- $18.5 million settlement resolving hospice eligibility and enrollment period False Claims Act allegations
- Patients enrolled without meeting the six-month terminal prognosis certification requirement
- Clinical documentation reviewed by investigators did not support continued enrollment for patients who remained on census for extended periods
- Physician certifications reviewed during the investigation contained characterizations inconsistent with underlying patient records
- A whistleblower who previously worked in ProHealth's clinical operations filed the qui tam complaint that initiated the investigation
The Eligibility Determination Problem
Medicare hospice eligibility requires certification by both the patient's primary physician and the hospice medical director that the patient's prognosis, in their clinical judgment, is six months or fewer to live if the illness follows its expected course. The standard is probabilistic rather than absolute — it reflects a clinical assessment of expected trajectory, not a guarantee. But certification must be grounded in genuine clinical examination and the patient's actual medical status at the time of certification or recertification.REVIEWED
The complaint allegations describe a pattern at ProHealth in which patients were admitted to hospice based on documentation that did not reflect the clinical picture that a review of underlying medical records would support — patients whose hospital discharge summaries, primary care notes, or diagnostic imaging indicated conditions that were chronic and serious but not terminal within the six-month window the hospice certification required. In several documented cases, patients who were enrolled in ProHealth's hospice program continued to receive or seek curative treatment for their primary diagnosis, which is inconsistent with the election of the hospice benefit, and in some cases lived for years beyond their initial certification date without recertification adequately documenting why continued hospice eligibility was appropriate.DOCUMENTED
Extended Enrollment Periods
Medicare allows hospice patients to be recertified for additional enrollment periods — initially two ninety-day periods, followed by unlimited sixty-day periods — as long as the certifying physician continues to find the patient eligible at each recertification review. The per-diem payment structure means that patients who remain enrolled longer generate more total Medicare revenue for the hospice provider, creating a financial incentive to retain patients past the point where their clinical condition genuinely supports continued eligibility.REVIEWED
The complaint findings include analysis of ProHealth's recertification documentation across a sample of long-stay patients — those enrolled for significantly longer than the six months the terminal prognosis standard contemplates. Investigators found that recertification documents for a substantial portion of these patients contained clinical characterizations that were not supported by contemporaneous nursing notes, physician visit records, or diagnostic data in the patient's file, suggesting that the recertifications were pro forma rather than reflecting genuine clinical assessment of the patient's current status.DOCUMENTED
Investigators found hospice enrollment continuing for patients whose nursing visit notes — written by ProHealth's own clinical staff — described conditions stable enough to raise questions about whether the patients still met the terminal prognosis standard required for Medicare hospice eligibility.
Whistleblower Origins and Clinical Staff Evidence
The qui tam complaint that initiated the investigation was filed by a former member of ProHealth's clinical staff who described the enrollment practices from firsthand experience. The whistleblower described internal pressure from administrative management to maintain census levels — the total number of enrolled patients — as a metric that affected staffing and financial planning, and characterized the admission process as giving insufficient weight to the clinical eligibility determination relative to the organizational interest in building and maintaining census.DOCUMENTED
The relator's testimony was corroborated by interviews with additional former clinical employees and by documentary evidence including internal communications discussing census targets and strategies for maintaining enrollment levels. Regulators and clinical advocates who work on hospice quality note that the per-diem payment structure inherently creates incentives that can push enrollment and retention decisions in directions that may not align with genuine patient needs or eligibility standards.REVIEWED
Resolution and Compliance Agreement
The $18.5 million settlement resolves the civil False Claims Act allegations. ProHealth also entered into a Corporate Integrity Agreement requiring independent clinical review of a sample of hospice admissions and recertifications annually, mandatory training for physicians who provide certification services, and reporting of any identified eligibility concerns to the HHS Office of Inspector General. The agreement is designed to create external visibility into ProHealth's eligibility practices during a five-year monitoring period.DOCUMENTED
Families whose relatives were enrolled in ProHealth hospice services and who have questions about whether their family member's clinical situation was accurately represented in enrollment documentation are encouraged to contact the HHS OIG fraud hotline or Watchdog Journal's secure tip channel at /tips.
Hospice Quality and Oversight Resources
Medicare provides a hospice quality reporting program that publishes quality measure data for all certified hospice providers, allowing patients and families to compare providers on clinical quality indicators. Families choosing a hospice provider for a family member should review both the quality measure data and the provider's inspection history, accessible through Medicare's Care Compare database. Hospice patients and families who have concerns about care quality or believe a patient was enrolled in hospice without meeting the clinical eligibility criteria have the right to request a physician review of the eligibility determination and to contact the applicable state survey agency. Individuals with knowledge of hospice billing or enrollment practices inconsistent with clinical eligibility standards are encouraged to contact the HHS OIG fraud hotline, which accepts tips about Medicare and Medicaid fraud on a confidential basis and can connect reporters with investigators who specialize in hospice compliance enforcement.
Sources behind this report
Have documents relevant to this story? Reach us through our tips channel.